TheMarker: a comprehensive database of therapeutic biomarkers
Y Zhang, Y Zhou, Y Zhou, X Yu, X Shen… - Nucleic Acids …, 2024 - academic.oup.com
Distinct from the traditional diagnostic/prognostic biomarker (adopted as the indicator of
disease state/process), the therapeutic biomarker (ThMAR) has emerged to be very crucial …
disease state/process), the therapeutic biomarker (ThMAR) has emerged to be very crucial …
YOLOv5-FPN: a robust framework for multi-sized cell counting in fluorescence images
Cell counting in fluorescence microscopy is an essential task in biomedical research for
analyzing cellular dynamics and studying disease progression. Traditional methods for cell …
analyzing cellular dynamics and studying disease progression. Traditional methods for cell …
Cannabis and cancer: unveiling the potential of a green ally in breast, colorectal, and prostate cancer
HA ALSalamat, SF Abuarab, HM Salamah… - Journal of Cannabis …, 2024 - Springer
Cancer comes in second place on the list of causes of death worldwide. In 2018, the 5-year
prevalence of breast cancer (BC), prostate cancer (PC), and colorectal cancer (CRC) were …
prevalence of breast cancer (BC), prostate cancer (PC), and colorectal cancer (CRC) were …
Computer-aided drug discovery strategies for novel therapeutics for prostate cancer leveraging next-generating sequencing data
Introduction Prostate cancer (PC) is the most common malignancy and accounts for a
significant proportion of cancer deaths among men. Although initial therapy success can …
significant proportion of cancer deaths among men. Although initial therapy success can …
Integration of pan-cancer cell line and single-cell transcriptomic profiles enables inference of therapeutic vulnerabilities in heterogeneous tumors
Single-cell RNA sequencing (scRNA-seq) greatly advanced the understanding of
intratumoral heterogeneity by identifying distinct cancer cell subpopulations. However …
intratumoral heterogeneity by identifying distinct cancer cell subpopulations. However …
Decoding drug response with structurized gridding map-based cell representation
A thorough understanding of cell-line drug response mechanisms is crucial for drug
development, repurposing, and resistance reversal. While targeted anticancer therapies …
development, repurposing, and resistance reversal. While targeted anticancer therapies …
[HTML][HTML] Inferring therapeutic vulnerability within tumors through integration of pan-cancer cell line and single-cell transcriptomic profiles
W Zhang, D Maeser, A Lee, Y Huang, RF Gruener… - bioRxiv, 2023 - ncbi.nlm.nih.gov
Single-cell RNA sequencing greatly advanced our understanding of intratumoral
heterogeneity through identifying tumor subpopulations with distinct biologies. However …
heterogeneity through identifying tumor subpopulations with distinct biologies. However …
Integration of Computational Pipeline to Streamline Efficacious Drug Nomination and Biomarker Discovery in Glioblastoma
D Maeser, RF Gruener, R Galvin, A Lee, T Koga… - Cancers, 2024 - mdpi.com
Simple Summary The major impact from this work is two-fold, first in providing a list of
reproducible candidate drugs nominated against multiple glioblastoma (GBM) datasets, and …
reproducible candidate drugs nominated against multiple glioblastoma (GBM) datasets, and …
Computational Approaches: A New Frontier in Cancer Research
S Srivastava, P Jain - Combinatorial Chemistry & High …, 2024 - ingentaconnect.com
Cancer is a broad category of disease that can start in virtually any organ or tissue of the
body when aberrant cells assault surrounding organs and proliferate uncontrollably …
body when aberrant cells assault surrounding organs and proliferate uncontrollably …